Delivery Order SPE2DB24D1104-SPE2DB25FYAF6
Award Date 4/24/25
Potential Completion Date 4/25/25
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,392.82 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of NovoLog 100 Unit/mL vials in 10mL quantities. This competitively awarded, firm fixed price delivery order is scheduled for completion by June 20, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on June 24, 2025, for NovoLog 100 Unit/mL vials (10 mL) valued at $7,248.80 with a firm fixed price structure. The award is non-set-aside and competitively awarded, with an ultimate completion date of June 25, 2025. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- The Defense Logistics Agency awarded a $1,803.20 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for NovoLog 100 Unit/mL vials (10 mL units). This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $11,703.15 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10mL units). The award, issued on June 6, 2025, with completion targeted for June 9, 2025, utilizes firm fixed pricing and was competitively awarded without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same city....
- The Defense Logistics Agency awarded a $1,944.90 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) on August 22, 2025, with an ultimate completion date of August 25, 2025. This contract was competitively awarded without any set-aside designation and is structured as a firm fixed price delivery order. The pharmaceutical product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL units) with a ceiling value of $13,640.14. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is expected to conclude by September 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $1,040.41. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $22,918.08 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10mL) on September 25, 2025. This contract utilizes firm fixed pricing and is not set-aside, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $1,450.65. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, and involves the delivery of insulin...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of NovoLog 100 Unit/ML vial 10ML insulin medication. This is a firm fixed-price delivery order with a ceiling value of $7,929.22 and an ultimate completion date of August 28, 2025. The contract is not set-aside and was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the...